04/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

04/2025

Apr 22, 2025, 13:59 | Blog
The systemic therapy options available for mCRPC - National Comprehensive Cancer Network
National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn: "Join us on April 28 for…
Apr 22, 2025, 13:49 | Science
Joshua Brody: How to measure T-cell BYSTANDER tumor killing to prevent antigen escape after cancer immunotherapy
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared an article…
Apr 22, 2025, 13:34 | Blog
Sampad Roy: A potential paradigm shift in breast cancer treatment
Sampad Roy, National Hospital Sales Manager at Unilever, shared a post on LinkedIn: "BREAKTHROUGH in the…
Apr 22, 2025, 13:19 | Blog
IASLC Board of Directors Elections 2025: Spotlight on Undesignated Seat Candidates
The International Association for the Study of Lung Cancer (IASLC) is currently conducting its 2025…
Apr 22, 2025, 13:02 | Oncolibrary
Trodelvy and Keytruda Achieve Breakthrough Results, Ushering in a New Era for ADCs in Breast Cancer
Gilead Sciences has announced that the combination of Trodelvy® (sacituzumab govitecan-hziy) and Keytruda® (pembrolizumab) has…
Apr 22, 2025, 12:05 | Radiotherapy
Success Rate and Survival After Stereotactic Radiotherapy
Stereotactic Radiotherapy, also known as stereotactic ablative radiotherapy (SABR), is a specialized form of radiation…
Apr 22, 2025, 11:13 | OncoDaily Pulse
New section on OncoDaily - A space that brings all career opportunities into one place
Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal, shared a post on LinkedIn: "Ever come across…
Apr 22, 2025, 11:10 | Oncolibrary
DESTINY-Breast09 trial: Enhertu + Pertuzumab Improves PFS in First-Line HER2+ Metastatic Breast Cancer
AstraZeneca and Daiichi Sankyo have announced that the combination of Enhertu (trastuzumab deruxtecan) and pertuzumab…
Apr 22, 2025, 11:06 | Blog
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "CD22 CAR T-cell immunotherapy is an…
Apr 22, 2025, 10:57 | Blog
Register for MASCC25 at the early bird rate - The Multinational Association of Supportive Care in Cancer
The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn: "Two days…
All: 2039 Posts: 1 - 10
Special Coverage